tiprankstipranks
SeaSpine Holdings (SPNE)
NASDAQ:SPNE
Holding SPNE?
Track your performance easily

SeaSpine Holdings (SPNE) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SPNE Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
SeaSpine
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SPNE Stock 12 Month Forecast

There Are No Analyst Ratings for SPNE In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SPNE Financial Forecast

No data currently available

SPNE Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

SPNE Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial
$6.75
Hold
Downgraded
11/02/22
Truist Securities Downgrades SeaSpine Holdings to Hold, Lowers Price Target to $6.75
BTIG
$19
Buy
Reiterated
11/01/22
BTIG Sticks to Their Buy Rating for SeaSpine Holdings (SPNE)
Cantor Fitzgerald
$21
Buy
Reiterated
10/11/22
SeaSpine (SPNE) reiterates at Overweight by Cantor Fitzgerald, Merger with Orthofix is "Highly Complimentary"Cantor Fitzgerald analyst Ross Osborn reiterated an Overweight rating and $21.00 price target on SeaSpine Holdings (NASDAQ: SPNE), following the companys report of updated Q3 and FY22 guidance, as well as announcement of a merger agreement with Orthofix (NASDAQ: OFIX).
Stifel Nicolaus
$16
Buy
Reiterated
08/03/22
"Outlook Moves Modestly Higher" Post Earning - Stifel reiterates SeaSpine Holdings (SPNE) at Buy with $16 Price TargetStifel analyst Mathew Blackman reiterated a Buy rating and $16.00 price target on SeaSpine Holdings (NASDAQ: SPNE), following the companys most recent quarterly report.
Piper Sandler
$12
Buy
Reiterated
08/03/22
Piper Sandler Maintains Overweight on SeaSpine Holdings, Lowers Price Target to $12
Canaccord Genuity
$18
Buy
Upgraded
08/02/22
Analyst Explains Why They Upgraded Their Rating on SeaSpine Holdings (SPNE)

SPNE Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SPNE Stock Forecast FAQ

What is SPNE’s average 12-month price target, according to analysts?
Currently, no data Available
What is SPNE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SPNE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SPNE a Buy, Sell or Hold?
      Currently, no data Available
      What is SeaSpine Holdings’s price target?
      Currently, no data Available
      What do analysts say about SeaSpine Holdings?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SPNE?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis